Shuchi Gulati

12PUBLICATIONS
63CO-AUTHORS
Electrochemical energy storage and conversionPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)HaematologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 30, 2024
Copper Drives Remodeling of Metabolic State and Progression of Clear Cell Renal Cell Carcinoma.

Megan E Bischoff, Behrouz Shamsaei, Juechen Yang

|Sep 10, 2024
Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma.

Pedro Barata, Catherine Tangen, Melissa Plets

|Jan 31, 2024
Copper drives remodeling of metabolic state and progression of clear cell renal cell carcinoma.

Megan E Bischoff, Behrouz Shamsaei, Juechen Yang

|Feb 21, 2023
Durvalumab plus Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: An Open-label, Nonrandomized, Phase II Clinical Trial.

Shuchi Gulati, McKenzie Crist, Muhammed Kashif Riaz

|Dec 26, 2022
Anticoagulant Therapy for Cancer-Associated Thrombosis : A Cost-Effectiveness Analysis.

Shuchi Gulati, Mark H Eckman

|Nov 03, 2022
Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition.

McKenzie Crist, Benyamin Yaniv, Sarah Palackdharry

Pageof 2